Category: Article – Media

Posted on

Article: H.C. Wainwright Keeps a Buy Rating on Aravive (ARAV)

Article - Media

H.C. Wainwright Keeps a Buy Rating on Aravive (ARAV)

Austin Angelo

SmarterAnalyst, 30 April 2020

In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Aravive (ARAV), with a price target of $15.00. The company’s shares closed last Thursday at $12.95.

According to TipRanks.com, Pantginis is a 5-star analyst with an average return of 14.5% and a 43.7% success rate. Pantginis covers the Healthcare sector, focusing on stocks such as Applied Genetic Technologies, Lineage Cell Therapeutics, and Iovance Biotherapeutics.

Read full article.

 

Comment: This company is at risk of collusion between a placement agent and naked short sellers.
Posted on

Article: Inovio to expand manufacturing of COVID-19 vaccine candidate with new CEPI grant

Article - Media

Inovio to expand manufacturing of COVID-19 vaccine candidate with new CEPI grant

Ciara Linnane

MarketWatch, 30 April 2020

Inovio Pharmaceuticals Inc. INO, -14.30% said Thursday it has received another grant from the Coalition for Epidemic Preparedness Innovations, or CEPI, an Oslo-based organization, to help it expend manufacturing of its COVID-19 vaccine candidate.

Read full article.

Comment: This is how they force people to sell. Many people buy on margin and as it goes lower they need more money.

Posted on

Article: Jim Cramer fires entire staff after soundboard calls him a stock pumper

Article - Media

Jim Cramer fires entire staff after soundboard calls him a stock pumper

Richard Landenstein

TheStonkMarket.com, 29 April 2020

Cramer has faced criticism recently by anonymous finance-focused Twitter accounts with accusations that he is a “shill” who pumps stock prices regardless of the consequences. “I block anyone who suggests I pump stocks. I’m one of the people.” Cramer explained. “It doesn’t matter what I’ve said in the past. It’s only a stock pump if I say it is.

Read full article.

Posted on

Article: H.C. Wainwright Maintains a Buy Rating on BerGenBio AS (BRRGF)

Article - Media

H.C. Wainwright Maintains a Buy Rating on BerGenBio AS (BRRGF)

Christine Brown

SmarterAnalyst, 29 April 2020

H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on BerGenBio AS (BRRGF) today and set a price target of NOK66.00. The company’s shares closed last Monday at $1.23.

According to TipRanks.com, Pantginis is a 5-star analyst with an average return of 8.2% and a 41.6% success rate. Pantginis covers the Healthcare sector, focusing on stocks such as Applied Genetic Technologies, Lineage Cell Therapeutics, and Iovance Biotherapeutics.

Read full article.

 

Comment: This company is at risk of collusion between a placement agent and naked short sellers.

RELATED:
Posted on

Article: Wirecard – what KPMG’s report found

Article - Media

Wirecard: what KPMG’s report found

The payments group had predicted vindication from a special audit — it did not arrive

Dan McCrum and Olaf Storbeck

Financial Times, 29 April 2020

For months Wirecard had confidently predicted that KPMG would vindicate its accounting and deliver a final riposte to its sceptics. Instead, the publication on Tuesday of a report from the accounting firm caused shares in the Dax 30 company to crash 26 per cent as investors learnt that KPMG’s investigators had faced obstacles in their attempts to verify that large parts of the business were real, and publication of full-year results would be delayed again. The shares fell another 7 per cent on Wednesday.

Paywall Access to Full Article.

Posted on

Article: 21.2 Million Reasons Aurora Cannabis Is a Terrible Stock

Article - Media, Publications

21.2 Million Reasons Aurora Cannabis Is a Terrible Stock

Sean Williams, 28 April 2020

If you thought the stock market has been taken on a wild ride over the past two months, then take a closer look at how marijuana stocks have fared since the beginning of April 2019. Following the first quarter of 2019, which saw numerous pot stocks rocket into the stratosphere, the past 13 months have erased anywhere from 50% to 95% of cannabis stock valuations.

Mind you, the long-term outlook for the legal weed industry is promising. Tens of billions of dollars in sales are conducted in the black market each year, meaning there’s a very real opportunity to move these illicit users to legal channels over time. But in the short run, U.S. pot stocks have been crushed by high tax rates, while Canadian cannabis companies have run into supply bottlenecks and shortages, depending on the province.
Continue reading “Article: 21.2 Million Reasons Aurora Cannabis Is a Terrible Stock”

Posted on

Article: Against the short-selling ban

Article - Media

Against the short-selling ban

Jamie Powell

Financial Times, 18 March 2020

In the past seven days, various bans on short-selling — the practice of betting on a stock falling in price — have come into effect across Italy, France, Belgium, Spain and Greece. The reason? In Italian regulator Consob’s own words: “these measures were made necessary by the strong turbulences triggered in the last days by the Covid-19 pandemic”.

Continue reading “Article: Against the short-selling ban”

Posted on

Article: Market manipulation persists in London’s financial district

Article - Media, Publications

Market manipulation persists in London’s financial district

LLB EDITOR, 27 April 2020

A total of 822 reports of suspected market manipulation were made to the FCA last year (year end Dec 31 2019) by market participants, suggesting that the problem is far from being eradicated, says RPC, the City-headquartered law firm.

The number of reports of market manipulation saw a slight increase last year, rising from 812 in 2018.

Market manipulation is the attempt to artificially increase or decrease the price of an asset, index or its derivative in order to make a gain. Following the LIBOR scandal that broke in 2012, the laws relating to market manipulation were significantly tightened up. This included criminalising the attempted manipulation of benchmarks (Financial Services Act 2012). Continue reading “Article: Market manipulation persists in London’s financial district”

Posted on

Article: Tesla short-sellers take record losses in battle with Elon Musk

Article - Media

Tesla short-sellers take record losses in battle with Elon Musk

Richard Henderson

Irish Times, 3 February 2020

Investors betting against Tesla suffered record losses of $5.8 billion (€5.2 billion) in January after the stock hit a new high, marking a win for chief executive Elon Musk in a long-running battle with short-sellers.

Mr Musk’s testy sparring online with notable short-sellers, including David Einhorn of Greenlight Capital, has become one of the fiercest rivalries in capital markets.

Read full article.

Posted on

Article: Short-seller Jim Chanos reveals bets against Dunkin’ Brands and Burger King’s parent

Article - Media, Publications

Short-seller Jim Chanos reveals bets against Dunkin’ Brands and Burger King’s parent

Matthew J. Belvedere, 26 April 2018

Short-seller Jim Chanos revealed Thursday on CNBC that he’s betting against two fast-food stocks. The founder and president of Kynikos Associates said in a “Squawk Box” interview that he’s shorting Dunkin’ Brands and Burger King’s parent Restaurant Brands International.

“We’ve been short these things for about a year,” said Chanos, who’s known for his past early negative calls on Enron and Tyco. On Thursday’s news, shares of Dunkin’ saw an initial 5 percent spike lower in premarket trading before recovering some of those losses. Dunkin’ had been up before Chanos’ comments. The stock opened lower.

Dunkin’ Brands CEO Nigel Travis pushed back on Chanos’ call in a Thursday afternoon interview with CNBC’s “Closing Bell.” “I love a challenge,” Travis said. “And that was a challenge before our earnings this morning. And I have a book coming out later this year, so I’ll take him head on. He’s absolutely wrong.” Shares of Restaurant Brands — owner of Burger King, Tim Hortons and Popeyes Louisiana Kitchen — sank about 3 percent on the news and then pared some of those declines. The stock opened down slightly.
Continue reading “Article: Short-seller Jim Chanos reveals bets against Dunkin’ Brands and Burger King’s parent”

Posted on

Article: tZERO secures US$5M equity investment

Article - Media

tZERO secures US$5M equity investment

Nawaz Ahmed

BraveNewCoin, 23 April 2020

tZERO is Patrick Byrnes’ attempt to utilize blockchain technology to replace traditional institutional market structures.

Project Medici intends to create a blockchain-based securities exchange, and Byrne had stated that he was interested in listing Overstock securities on a blockchain-based exchange. The project was officially announced on October 6th at the Inside Bitcoins Las Vegas conference.

The long term goal was to compete with the Depository Trust and Clearing Corporation (DTCC).

Read full article.

Posted on

Article: SEC Delays CAT Deadline for Broker-Dealers Amid COVID-19

Article - Media

SEC Delays CAT Deadline for Broker-Dealers Amid COVID-19

Celeste Skinner

FinanceMagnates, 21 April 2020

The Securities and Exchange Commission (SEC) has yet again pushed back the date for when broker-dealers will need to report data to the regulator’s Consolidated Audit Trail (CAT), allowing firms to instead focus their efforts on dealing with the coronavirus pandemic and the impact it is having on their businesses.

In a statement published on Monday, the US regulator said that it had voted in favour of issuing two exemptive orders in which it will move the CAT implementation forward, with the first action required on the 22nd of June, 2020.

Read full article.

Posted on

Article: Should You Be Concerned About Benitec Biopharma Limited’s (NASDAQ:BNTC) Historical Volatility?

Article - Media, Publications

Should You Be Concerned About Benitec Biopharma Limited’s (NASDAQ:BNTC) Historical Volatility?

Simply Wall St, 20 April 2020

Anyone researching Benitec Biopharma Limited (NASDAQ:BNTC) might want to consider the historical volatility of the share price. Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility. The first category is company specific volatility. This can be dealt with by limiting your exposure to any particular stock. The second sort is caused by the natural volatility of markets, overall. For example, certain macroeconomic events will impact (virtually) all stocks on the market. Continue reading “Article: Should You Be Concerned About Benitec Biopharma Limited’s (NASDAQ:BNTC) Historical Volatility?”

Posted on

Article: Pandemic May Disrupt Discovery In Credit Suisse Forex Case

Article - Media, Publications

Pandemic May Disrupt Discovery In Credit Suisse Forex Case

Dean Seal, 17 April 2020

Counsel for investors and Credit Suisse cited the COVID-19 pandemic Monday when they asked a New York federal judge to push their discovery deadlines in a suit over alleged foreign exchange market manipulation by nine weeks.

In a letter to U.S. District Judge Lorna G. Schofield, attorneys for both sides in the long-running litigation said that in light of the threat to public health posed by the novel coronavirus, as well as the disruptions it has caused in air travel, continued discovery efforts would be risky and exceedingly difficult. Continue reading “Article: Pandemic May Disrupt Discovery In Credit Suisse Forex Case”

THE DOLLAR HAS NO INTRINSIC VALUE : DO YOUR ASSETS?